Insurance reimbursement for iOvera

Insurance reimbursement for iOvera refers to the process by which a health insurance provider pays back a patient or healthcare provider for costs incurred from an iOvera procedure. Most commercial insurers, such as Aetna and UnitedHealthcare, classify iOvera as investigational and typically deny coverage based on their published medical policies.

Medicare does not have a national coverage determination (NCD) for iOvera, so local Medicare Administrative Contractors (MACs), like Noridian or Palmetto GBA, decide case-by-case and often require prior authorization. Blue Cross Blue Shield plans in states like Texas and California list iOvera under experimental treatments with no routine reimbursement.

Insurers generally require CPT code 64640 when submitting claims for iOvera procedures, but denial rates exceed 80% according to recent claims data from 2023. Patients can appeal denials using letters of medical necessity that cite peer-reviewed studies showing pain reduction outcomes after iOvera treatment.

Some workers’ compensation carriers approve limited reimbursement if documentation proves conservative therapies failed before trying iOvera, https://yourinsurance.info states. Out-of-network benefits may allow partial reimbursement if patients meet high deductibles or out-of-pocket maximums first, as shown in Cigna’s plan documents from 2022.